39 filings
8-K
PRLD
Prelude Therapeutics Inc
10 Apr 24
Departure of Directors or Certain Officers
4:05pm
8-K
PRLD
Prelude Therapeutics Inc
15 Feb 24
Prelude Therapeutics Reports Full Year 2023 Financial Results and Outlines Key Objectives for 2024
4:22pm
8-K
PRLD
Prelude Therapeutics Inc
11 Dec 23
Prelude Therapeutics Announces $25 Million Private Placement
9:17am
8-K
PRLD
Prelude Therapeutics Inc
1 Nov 23
Prelude Announces Strategic Pipeline Progress and Updates, including its Partnership with AbCellera, and Reports Third Quarter Financial Results
4:23pm
8-K
PRLD
Prelude Therapeutics Inc
3 Aug 23
Prelude Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
8:10am
8-K
jip m5gnrf369v0e5b
21 Jun 23
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
rnfm4b5je6ue8f
1 Jun 23
Regulation FD Disclosure
4:25pm
8-K
y1hprouzu7t6e nh7ynk
19 May 23
Prelude Therapeutics Announces Launch of Proposed Public Offering
4:06pm
8-K
cz9yjjidd1vnbzt cy76
17 May 23
Other Events
4:03pm
8-K
04v6r31 pd
8 May 23
Prelude Therapeutics Announces First Quarter 2023 Financial Results and Operations Update
8:06am
8-K
5d9fmtjm9 utma
15 Mar 23
Entry into a Material Definitive Agreement
4:38pm
8-K
oko nur13byw197qo
15 Mar 23
Prelude Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Update
8:31am
8-K
tmtvyge2tb5xq
14 Feb 23
Regulation FD Disclosure
11:14am
8-K
us1cgb9s23
23 Jan 23
Amendments to Articles of Incorporation or Bylaws
4:16pm
8-K
iy1oydfg 9ro53cew1q
9 Jan 23
Regulation FD Disclosure
8:01am
8-K
lvcczcfn
14 Nov 22
Prelude Therapeutics Announces Third Quarter 2022 Financial Results and Provides Business Update
8:21am
8-K
zq4a5tuttsj591
9 Aug 22
Prelude Therapeutics Announces Second Quarter 2022 Financial Results and Business Update
8:02am
8-K
2niv7oobrhjvz cigqy
21 Jun 22
Submission of Matters to a Vote of Security Holders
8:00am
8-K
0mvf5ee8azz
10 May 22
Prelude Therapeutics Announces First Quarter 2022 Financial Results and Operations Update
8:05am
8-K
q3gcn15sxuje195t
8 Apr 22
Departure of Directors or Certain Officers
4:30pm